Celldex Therapeutics (CLDX) Net Margin (2010 - 2026)
Celldex Therapeutics (CLDX) posted Net Margin of -334104.55% for Q2 2026, down 326351.12 percentage points from -7753.42% a year earlier but up 190462.12 percentage points from the prior quarter.
Celldex Therapeutics (CLDX) Net Margin (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Net Margin at Celldex Therapeutics was -190248.10%, down 186801.01 percentage points year-over-year; for FY2025, it was -16750.81%, down 14501.52 percentage points from FY2024.
- Annual Net Margin shows a five-year change of -15944.93 percentage points (FY2020 to FY2025).
- In prior years, Celldex Therapeutics' Net Margin was -2249.29% in FY2024 (-194.53 pp), -2054.76% in FY2023 (+2710.83 pp), -4765.59% in FY2022 (-3249.55 pp) and -1516.04% in FY2021 (-710.16 pp).
- Quarterly Net Margin has run from a low of -524566.67% in Q1 2026 to a high of -1048.32% in Q4 2023 over five years.
- On a year-over-year basis, Net Margin has declined in each of the last three quarters, with an average year-over-year change of -128742.13 percentage points over the last seven quarters.
- The strongest year-over-year quarter for Net Margin in the past five years was Q1 2025, with a gain of 13289.76 percentage points; the weakest was Q1 2026, with a drop of 516825.66 percentage points.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 32.99% |
| 10 | Celldex Therapeutics | 2.47 Bn | 2.47 Bn | - | -334,104.55% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -334,104.55% |
| Mar 31, 2026 | -524,566.67% |
| Dec 31, 2025 | -67,239.67% |
| Jun 30, 2025 | -7,753.42% |
| Mar 31, 2025 | -7,741.01% |
| Dec 31, 2024 | -4,008.51% |
| Sep 30, 2024 | -1,319.99% |
| Jun 30, 2024 | -1,434.83% |
| Mar 31, 2024 | -21,030.77% |
| Dec 31, 2023 | -1,048.32% |
| Sep 30, 2023 | -2,522.08% |
| Jun 30, 2023 | -11,381.34% |
| Mar 31, 2023 | -3,036.30% |
| Dec 31, 2022 | -1,642.10% |
| Sep 30, 2022 | -6,580.84% |
| Jun 30, 2022 | -22,088.34% |
| Mar 31, 2022 | -13,247.13% |
| Dec 31, 2021 | -6,032.34% |
| Sep 30, 2021 | -13,367.32% |
| Jun 30, 2021 | -384.28% |
Celldex Therapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=CLDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "CLDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=CLDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();